International Conference on Molecular Cancer Biology and Cancer Cell (ICMCBCC - 26)

This track focuses on the latest discoveries in cancer cell biology, including cellular mechanisms and pathways that drive tumorigenesis. Researchers are encouraged to present novel findings that enhance our understanding of cancer progression and metastasis.

This session will explore recent advancements in the identification and validation of cancer biomarkers for diagnosis and prognosis. Contributions that highlight innovative approaches to biomarker discovery and their clinical applications are welcome.

This track will cover cutting-edge imaging technologies that improve cancer detection and monitoring. Presentations should focus on novel imaging modalities and their impact on patient management and treatment outcomes.

This session will delve into the role of tumor suppressor genes in cancer biology, including their mechanisms of action and implications for therapy. Researchers are invited to discuss recent findings that elucidate the pathways regulated by these critical genes.

This track will address the role of protein kinases in cancer signal transduction pathways. Contributions that explore therapeutic targeting of these kinases and their implications for cancer treatment are highly encouraged.

This session will highlight the use of transgenic mice and other model organisms in cancer research. Presentations should focus on how these models contribute to our understanding of cancer biology and therapeutic development.

This track will explore the relationship between apoptosis and cancer treatment strategies. Researchers are invited to present studies that investigate how modulation of apoptotic pathways can enhance therapeutic efficacy.

This session will focus on the application of RNA interference technologies in cancer biology and therapy. Contributions that demonstrate innovative RNA-based strategies for targeting cancer cells are encouraged.

This track will examine the molecular mechanisms underlying carcinogenesis and mutagenesis. Researchers are invited to present their findings on environmental and genetic factors that contribute to cancer development.

This session will explore integrative methodologies that combine various scientific disciplines to advance cancer research. Contributions that highlight interdisciplinary approaches and collaborative efforts are particularly welcome.

This track will focus on the discovery and development of novel anti-cancer drugs and therapeutic strategies. Presentations should highlight innovative compounds and their mechanisms of action in the context of cancer therapy.